Northway Biotech
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, "The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply."
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/757061/Northway-Biotech-Set-to-Launch-Advanced-Microbial-and-Mammalian-GMP-Facilities-in-Massachusetts
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile7.10.2024 09:30:00 CEST | Press release
VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce that, further to its news release on June 27, 2024, it has entered into a definitive share purchase agreement dated October 4, 2024 ("Agreement") with Nittetsu Mining Co., Ltd. ("Nittetsu") and Santiago Metals Investment Holdings II SL and Santiago Metals Investment Holdings II-A LLC (together, the "Vendors"), pursuant to which Camino and Nittetsu will jointly acquire (through a Chilean entity co-owned 50/50 by Camino and Nittetsu) all of the issued and outstanding shares of Cuprum Resources Chile SpA ("Cuprum"), a Chilean incorporated company and the owner of the Puquios Project ("Puquios" or the "Project"), a construction-ready copper project located in Chile (the "Transaction"). In connection with the Transaction, and subject to approval of the TSX Venture Exchange (the "Exchange"), Camino intends to undertake a private placement of
Terry Lynch Joins BioNxt as Capital Markets Advisor7.10.2024 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that Terry Lynch has joined the BioNxt team as a capital markets advisor. Mr. Lynch brings decades of start-up and emerging growth capital markets experience in the resource and bioscience sectors, including finance and M&A, as well as an extensive and influential network of market professionals. Mr. Lynch is currently the CEO of Power Nickel Inc., a publicly traded mining company with an advanced high grade polymetallic Nickel project based in Quebec, Canada, and is a cofounder of TSX and NASDAQ listed Cardiol Therapeutics, a market leader in pharmaceutical grade CBD production and the developer of groundbreaking therapies for the treatment of cardiovascular disease. He holds a joint honours degree in business administration and economics from St. Francis Xavier University. Mr. Lynch is also the founder and managing director of Sav
Re-Inventing the Runway - Immersive Exhibition Launch7.10.2024 02:00:00 CEST | Press release
Fashion Just Got Hacked - Welcome to the New Runway LONDON, ENGLAND / ACCESSWIRE / October 7, 2024 / Runway Magazine invites you to the launch of "Re-Inventing the Runway," a groundbreaking immersive exhibition available to everyone, anywhere. This unique exhibition redefines the traditional runway show, transforming it into an interactive, real-time event that engages audiences across all devices - mobile, desktop, and through the Meta Quest 3S headset. Seamlessly accessible through RUNWAYMAGAZINES.com and RUNWAYUNIVERSE.com, this exhibition is not just a glimpse into the world of creativity but a portal to explore, interact, and become part of an evolving narrative. Re-Inventing the Runway - immersive exhibition Re-Inventing the Runway - immersive exhibition by RUNWAY MAGAZINE Beyond the Screen: An Immersive Reality "Re-Inventing the Runway" merges the world of imagination with cutting-edge technology, creating a living animation where dreams and reality blend seamlessly. The moment
Tonogold Posts Presentation Detailing the JAG Minerals Acquisition3.10.2024 09:00:00 CEST | Press release
Highlights TONOGOLD highlights the historic, low risk districts of uranium and vanadium production close to existing mineral production and processing. The Company will seek to accelerate the exploration, development and production of these critically important minerals. WOODLAND HILLS, CA / ACCESSWIRE / October 3, 2024 / TONOGOLD Resources Inc. (OTC PINK:TNGL) ("TONOGOLD" or the "Company") is pleased to inform shareholders that it has posted a presentation on its website detailing the previously announced acquisition of JAG Minerals Pty Ltd. This acquisition is the culmination of 12 months of work by both the TONOGOLD and JAG teams and, TONOGOLD believes, will lead to a leader in the uranium industry. The presentation can be accessed via this link: https://tonogold.com/corporate/presentation/ TONOGOLD CEO William Hunter stated: "We're pleased to be moving this transaction forward and look forward to operating these assets upon closing. The strategic importance of nuclear power in an i
New Preservica Application Drives Greater Efficiency and Transparency for UK Local Government Records3.10.2024 04:00:00 CEST | Press release
OXFORD, UK / ACCESSWIRE / October 3, 2024 / Preservica, a recognized leader in Active Digital Preservation™, has launched a new edition of its popular archiving software that's purpose-designed to enable UK Local Authority record-keeping teams to more efficiently maintain reliable, complete and retrievable long-term and permanent digital records in alignment with their obligations under the UK Public Records Act, Freedom of Information Act (FOIA) and UK GDPR (General Data Protection Regulation). Speed, automation and more efficient services Developed in collaboration with its community of nearly 50 UK local authority Records Offices and Archives, the new Preservica UK Local Government edition comes ready-configured with folders, metadata and workflows to enable record-keeping teams to rapidly create a trusted repository for managing and protecting many different types of long-term government records and digital formats including: Democratic Services - Councils and Committees Adult & Ch
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom